Can proliferation signal inhibitor-induced tregs really reflect transplantation tolerance in clinical solid organ transplantation?

International Reviews of Immunology

Volumn 28, Issue 5, 2009, Pages 367-375

  Li, Suping ^a,b   Kuang, Anren ^a   Huang, Rui ^a  

^a SICHUAN UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

proliferation signal inhibitors; regulatory T cells; tolerance; transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; PROLIFERATION SIGNAL INHIBITOR; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE;

ALLOIMMUNITY; ALLOTRANSPLANTATION; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOKINE PRODUCTION; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION; TRANSPLANTATION TOLERANCE; ANIMAL; DRUG EFFECT; IMMUNOLOGY; ORGAN TRANSPLANTATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 73349100011     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180903093788     Document Type: Review

References (46)

1. M.M. Lopez, J.E. Valenzuela, F.C. Alvarez, M.R. López-Alvarez, G.S. Cecilia, P.P. Paricio. Long-term problems related to immunosuppression. Transpl Immunol 17: 31-35, 2006. (Pubitemid 44828802)
2. + suppressor T cells: More questions than answers. Nat Rev Immunol 2: 389-400, 2002. (Pubitemid 37328746)
3. Y. Belkaid and B.T. Rouse. Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360, 2005. (Pubitemid 41716772)
4. K.J. Wood and S. Sakaguchi. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210, 2003. (Pubitemid 37323205)
5. Y. Nishizuka and T. Sakakura. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166: 753-755, 1969.
6. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. Immunologic selftolerancemaintained by activated T cells expressing IL-2 receptor a -chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164, 1995.
7. S. Hori, T. Nomura, and S. Sakaguchi. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003. (Pubitemid 36222930)
8. + regulatory T cells. Nat Immunol 4: 330-336, 2003. (Pubitemid 36432314)
9. O.F. Bueno, E.B. Brandt, M.E. Rothenberg, and J.D. Molkentin. Defective T cell development and function in calcineurin A beta-deficient mice. PNAS 99: 9398-9403, 2002. (Pubitemid 34764625)
10. S.J. Bensinger, P.T.Walsh, J. Zhang,M. Carroll, R. Parsons, J.C. Rathmell, et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 172: 5287-5296, 2004. (Pubitemid 38542026)
11. L.M. D'Cruz and L. Klein. Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 6: 1152-1159, 2005. (Pubitemid 41541793)
12. K.L. Napoli and P.J. Taylor. From beach to bedside: History of the development of sirolimus. Ther Drug Monit 23: 559-586, 2001. (Pubitemid 32912281)
13. W. Gao, Y. Lu, B. El-Essawy, M. Oukka, V.K. Kuchroo, and T.B. Strom. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 7: 1722-1732, 2007. (Pubitemid 46905432)
14. + regulatory T cells. Blood 105: 4743-4748, 2005. (Pubitemid 40807298)
15. M. Hara, C.I. Kingsley, M. Niimi, S. Read, S.E. Turvey, A.R. Bushell, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789-3796, 2001. (Pubitemid 32224903)
16. L. Graca, S.P. Cobbold, and H. Waldmann. Identification of regulatory T cells in tolerated allografts. J Exp Med 195: 1641-1646, 2002. (Pubitemid 34666077)
17. K.J. Wood and S. Sakaguchi. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210, 2003. (Pubitemid 37323205)
18. + T cells in human kidney transplant recipients. J Am Soc Nephrol 14: 1643-1651, 2003. (Pubitemid 36687068)
19. + regulatory T cells in renal transplant recipients. Transplantation 82: 550-557, 2006. (Pubitemid 44290262)
20. M. Noris, F. Casiraghi, M. Todeschini, P. Cravedi, D. Cugini, G. Monteferrante, et al. Regualtory T cells and T cell depletion: Role of immunosuppressive drugs. J Am Soc Nephrol 18: 1007-1018, 2007. (Pubitemid 46434518)
21. P. Ruggenentic, N. Perico, E. Gotti, P. Cravedi, V. D'Agati, E. Gagliardini, et al. Sirolimus versus cylosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. Transplantation 84: 956-964, 2007. (Pubitemid 350287376)
22. + T cells in human kidney transplant recipients. J Am Soc Nephrol 14: 1643-1651, 2003. (Pubitemid 36687068)
23. + T cells after renal transplantation. Transplant Proc 39: 2721-2723, 2007. (Pubitemid 350088119)
24. D. San Segundo, J.C. Ruiz, G. Fernandez-Fresnedo, M. Izquierdo, C. Gómez- Alamillo, E. Cacho, et al. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. Transplant Proc 38: 2391-2393, 2006. (Pubitemid 44693735)
25. S. Hariharan, C.P. Johnson, B.A. Bresnahan, S.E. Taranto, M.J. McIntosh, D. Stablein, et al. Improved graft survival after renal transplantation in theUnited States, 1988 to 1996. N Engl J Med 342: 605-612, 2000. (Pubitemid 30118412)
26. H.U. Meier-Kriesche, J.D. Schold, T.R. Srinivas, and B. Kaplan. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004. (Pubitemid 38282293)
27. B.J. Nankivell and J.R. Chapman. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 81: 643-654, 2006.
28. M.H. Sayegh and G. Remuzzi. Clinical update: Immunosuppression minimization. Lancet 369: 1676-1678, 2007.
29. A.W. Goldrath, C.J. Luckey, R. Park, C. Benoist, and D. Mathis. The molecular program induced in T cells undergoing homeostatic proliferation. PNAS 101: 16885-16890, 2004. (Pubitemid 39601333)
30. M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184: 387-396, 1996. (Pubitemid 26324092)
31. S. Sakaguchi. Regulatory T cells: Key controllers of immunologic self tolerance. Cell 101: 455-458, 2000.
32. + cells: A naturally occurring population of regulatory T cells. Blood 98: 2736-2744, 2001.
33. + T regulatory cells. Nat Immunol 4: 337-342, 2003. (Pubitemid 36432315)
34. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22: 329-341, 2005. (Pubitemid 40387475)
35. + regulatory T cells. Blood 105: 4743-4748, 2005. (Pubitemid 40807298)
36. R.A. Cavinato, F. Casiraghi, N. Azzollini, P. Cassis, D. Cugini, M. Mister, et al. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 79: 1034-1039, 2005. (Pubitemid 40663993)
37. D.O. Taylor, L.B. Edwards,M.M. Boucek, E.P. Trulock, D.A.Waltz, B.M. Kack, et al. Registry of the International Society for Heart and Lung Transplantation: Twentythird official adult heart transplantation report-2006. J Heart Lung Transplant 25: 869-879, 2006. (Pubitemid 44143013)
38. C.C. Baan, B.J. van der Mast, M. Klepper, W.M. Mol, A.M. Peeters, S.S. Korevaar, et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of Foxp3 in human T cells. Transplantation 80: 110-117, 2005. (Pubitemid 40980903)
39. E.M. Shevach. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25: 195-201, 2006. (Pubitemid 44224153)
40. J.A. Bluestone and A.K. Abbas. Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257, 2003. (Pubitemid 37323210)
41. A. Scheffold, K.M. Murphy, and T. Hofer. Competition for cytokines: Treg cells take all. Nat Revs Immunol 8: 1285-1287, 2007. (Pubitemid 350131165)
42. C.L. Maynard, L.E. Harrington, K.M. Janowski, J.R. Oliver, C.L. Zindl, A.Y. Rudensky, et al. Regulatory T cells expressing interleukin 10 development from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941, 2007. (Pubitemid 47300007)
43. L. Strauss, T.L. Whiteside, A. Knights, C. Bergmann, A. Knuth, and A. Zippelius. Selective survival of naturally occurring human CD4+CD25+ Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178: 320-329, 2007. (Pubitemid 46033615)
44. D. Valmori, V. Tosello, N.E. Souleimanian, E. Godefroy, L. Scotto, and Y.Weng, et al. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol 177: 944-949, 2006. (Pubitemid 44036595)
45. S. Basu, T. Golovina, T. Mikheeva, C.H. June, and J.L. Riley. Cutting edge: Foxp3- mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180: 5794-5798, 2008.
46. A. Demirkiran, T.K. Hendrikx, C.C. Baan, and L.J. van der Laan. Impact of immunosuppressive drugs on CD4+CD25+ Foxp3+ regulatory T cells: Doer in vitro evidence translate to the clinical setting? Transplantation 85: 783-789, 2008. (Pubitemid 351440740)